A Rapid and Sensitive Next-Generation Sequencing Method to Detect RB1 Mutations Improves Care for Retinoblastoma Patients and Their Families

Retinoblastoma is a childhood eye malignancy that can lead to the loss of vision, eye(s), and sometimes life. The tumors are initiated by inactivating mutations in both alleles of the tumor-suppressor gene, RB1, or, rarely, by MYCN amplification. Timely identification of a germline RB1 mutation in blood samples or either somatic RB1 mutation or MYCN amplification in tumors is important for effective care and management of retinoblastoma patients and their families. However, current procedures to thoroughly test RB1 mutations are complicated and lengthy.

http://jmd.amjpathol.org/article/S1525-1578(16)30029-0/fulltext?rss=yes

Source: Journal of Molecular Diagnostics - May 3, 2016 Category: Pathology Authors: Wenhui L. Li, Jonathan Buckley, Pedro A. Sanchez-Lara, Dennis T. Maglinte, Lucy Viduetsky, Tatiana V. Tatarinova, Jennifer G. Aparicio, Jonathan W. Kim, Margaret Au, Dejerianne Ostrow, Thomas C. Lee, Maurice O'Gorman, Alexander Judkins, David Cobrinik, Ti Tags: Regular article Source Type: research